Placebo, nocebo, and learning mechanisms

Handbook of Experimental Pharmacology

Volumn 225, Issue , 2014, Pages 17-34

  Colloca, Luana ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Conditioning; Drugmimic effects; Expectation; Observational learning; Verbal suggestion; Vicarious hypoalgesia

Indexed keywords

AMPHETAMINE; CYCLOPHOSPHAMIDE; NARCOTIC ANALGESIC AGENT; SACCHARIN; SCOPOLAMINE; SEROTONIN AGONIST;

ANALGESIA; ANALGESIC ACTIVITY; ANTIDIABETIC ACTIVITY; ARTICLE; ASSOCIATION; ATTENTION DEFICIT DISORDER; CONDITIONING; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL ANIMAL; HUMAN; LEARNING; MEDICAL INFORMATION; MEMORY; NOCEBO EFFECT; NONHUMAN; PHARMACOLOGICAL CONDITIONING; PHARMACOLOGICAL STIMULATION; PLACEBO EFFECT; VERBAL COMMUNICATION; ANIMAL; INTERPERSONAL COMMUNICATION;

ANIMALS; COMMUNICATION; CONDITIONING (PSYCHOLOGY); HUMANS; LEARNING; NOCEBO EFFECT; PLACEBO EFFECT;

EID: 84921766825     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-662-44519-8_2     Document Type: Article

References (66)

1. Ader R (1987) Conditioned immune responses: adrenocortical influences. Prog Brain Res 72:79–90
2. Ader R, Cohen N (1982) Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 215:1534–1536
3. Ader R, Grota LJ, Cohen N (1987) Conditioning phenomena and immune function. Ann N Y Acad Sci 496:532–544
4. Ader R, Felten D, Cohen N (1990) Interactions between the brain and the immune system. Annu Rev Pharmacol Toxicol 30:561–602
5. Ader R, Kelly K, Moynihan JA, Grota LJ, Cohen N (1993) Conditioned enhancement of antibody production using antigen as the unconditioned stimulus. Brain Behav Immun 7:334–343
6. Ader R, Cohen N, Felten D (1995) Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 345:99–103
7. Ader R, Mercurio MG, Walton J, James D, Davis M, Ojha V, Kimball AB, Fiorentino D (2010) Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med 72:192–197
8. Alvarez-Buylla R, Carrasco-Zanini J (1960) A conditioned reflex which reproduces the hypoglycemic effect of insulin. Acta Physiol Lat Am 10:153–158
9. Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19:484–494
10. Benedetti F, Amanzio M, Baldi S, Casadio C, Cavallo A, Mancuso M, Ruffini E, Oliaro A, Maggi G (1998) The specific effects of prior opioid exposure on placebo analgesia and placebo respiratory depression. Pain 75:313–319
11. Benedetti F, Amanzio M, Baldi S, Casadio C, Maggi G (1999) Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci 11:625–631
12. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I (2003) Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 23:4315–4323
13. Benedetti F, Colloca L, Torre E, Lanotte M, Melcarne A, Pesare M, Bergamasco B, Lopiano L (2004) Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nat Neurosci 7:587–588
14. Benedetti F, Lanotte M, Lopiano L, Colloca L (2007a) When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 147:260–271
15. Benedetti F, Pollo A, Colloca L (2007b) Opioid-mediated placebo responses boost pain endurance and physical performance: is it doping in sport competitions? J Neurosci 27:11934–11939
16. Benedetti F, Lanotte M, Colloca L, Ducati A, Zibetti M, Lopiano L (2009) Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response. J Physiol 587:3869–3883
17. Chung SK, Price DD, Verne GN, Robinson ME (2007) Revelation of a personal placebo response: its effects on mood, attitudes and future placebo responding. Pain 132:281–288
18. Colloca L, Benedetti F (2006) How prior experience shapes placebo analgesia. Pain 124:126–133
19. Colloca L, Benedetti F (2009) Placebo analgesia induced by social observational learning. Pain 144:28–34
20. Colloca L, Finniss D (2012) Nocebo effects, patient-clinician communication, and therapeutic cutcomes. JAMA 307:567–568
21. Colloca L, Miller FG (2011a) Harnessing the placebo effect: the need for translational research. Philos Trans R Soc Lond B Biol Sci 366:1922–1930
22. Colloca L, Miller FG (2011b) How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond B Biol Sci 366:1859–1869
23. Colloca L, Miller FG (2011c) The nocebo effect and its relevance for clinical practice. Psychosom Med 73:598–603
24. Colloca L, Sigaudo M, Benedetti F (2008a) The role of learning in nocebo and placebo effects. Pain 136:211–218
25. Colloca L, Tinazzi M, Recchia S, le Pera D, Fiaschi A, Benedetti F, Valeriani M (2008b) Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 139:306–314
26. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F (2010) How the number of learning trials affects placebo and nocebo responses. Pain 151:430–439
27. Colloca L, Flaten MA, Meissner K (2013a) Placebo and pain: from bench to bedside. Elsevier, Oxford
28. Colloca L, Klinger R, Flor H, Bingel U (2013b) Placebo analgesia: psychological and neurobiological mechanisms. Pain 154:511–514
29. Engert VP, Franziska P, Miller R, Kirschbaum C, Singer T (2014) Cortisol increase in empathic stress is modulated by social closeness and observation modality. Psychoneuroendocrinology 45:192–201
30. Fiorio M, Recchia S, Corra F, Simonetto S, Garcia-Larrea L, Tinazzi M (2012) Enhancing non-noxious perception: behavioural and neurophysiological correlates of a placebo-like manipulation. Neuroscience 217:96–104
31. Fiorio M, Recchia S, Corra F, Tinazzi M (2014) Behavioural and neurophysiological investigation of the influence of verbal suggestion on tactile perception. Neuroscience 258:332–339
32. Flaten MA, Simonsen T, Olsen H (1999) Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med 61:250–255
33. Galef BG Jr, Durlach PJ (1993) Absence of blocking, overshadowing, and latent inhibition in social enhancement of food preferences. Anim Learn Behav 21:214–220
34. Giang DW, Goodman AD, Schiffer RB, Mattson DH, Petrie M, Cohen N, Ader R (1996) Conditioning of cyclophosphamide-induced leukopenia in humans. J Neuropsychiatry Clin Neurosci 8:194–201
35. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, Canbay AE, Michel MC, heemann U, Schedlowski M (2002) Behavioral conditioning of immunosuppression is possible in humans. FASEB J 16:1869–1873
36. Guo JY, Wang JY, Luo F (2010) Dissection of placebo analgesia in mice: the conditions for activation of opioid and non-opioid systems. J Psychopharmacol 24:1561–1567
37. Guo JY, Yuan XY, Sui F, Zhang WC, Wang JY, Luo F, Luo J (2011) Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice. Psychopharmacology (Berl) 217:83–90
38. Hrobjartsson A, Kaptchuk TJ, Miller FG (2011) Placebo effect studies are susceptible to response bias and to other types of biases. J Clin Epidemiol 64:1223–1229
39. Hunter T, Siess F, Colloca L (2014) Socially-induced placebo analgesia: a comparison of a pre-recorded versus live face-to-face observation. Eur J Pain 18(7):914–922
40. Kessner S, Wiech K, Forkmann K, Ploner M, Bingel U (2013) The effect of treatment history on therapeutic outcome: an experimental approach. JAMA Int Med 1–2
41. Kirsch I (1985) Response expectancy as a determinant of experience and behavior. Am Psychol 40:1189–1202
42. Kirsch I, Weixel LJ (1988) Double-blind versus deceptive administration of a placebo. Behav Neurosci 102:319–323
43. Lanzetta JT, Orr SP (1980) Influence of facial expressions on the classical conditioning of fear. J Pers Soc Psychol 39:1081–1087
44. Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM (2001) Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson’s disease. J Neurophysiol 86:249–260
45. Luparello TJ, Leist N, Lourie CH, Sweet P (1970) The interaction of psychologic stimuli and pharmacologic agents on airway reactivity in asthmatic subjects. Psychosom Med 32:509–513
46. Mazzoni G, Foan L, Hyland ME, Kirsch I (2010) The effects of observation and gender on psychogenic symptoms. Health Psychol 29:181–185
47. Olness K, Ader R (1992) Conditioning as an adjunct in the pharmacotherapy of lupus erythematosus. J Dev Behav Pediatr 13:124–125
48. Pacheco-Lopez G, Riether C, Doenlen R, Engler H, Niemi MB, Engler A, Kavelaars A, Heijnen CJ, Schedlowski M (2009) Calcineurin inhibition in splenocytes induced by pavlovian conditioning. FASEB J 23:1161–1167
49. Pavlov IP (1927) Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. Oxford University Press, London
50. Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS (1999) An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83:147–156
51. Reiss R (1980) Pavlovian conditioning and human fear: an expectancy model. Behav Ther 11:380–396
52. Rescorla RA (1988a) Behavioral studies of Pavlovian conditioning. Annu Rev Neurosci 11:329–352
53. Rescorla RA (1988b) Pavlovian conditioning. It’s not what you think it is. Am Psychol 43:151–160
54. Rodriguez-Raecke R, Doganci B, Breimhorst M, Stankewitz A, Buchel C, Birklein F, May A (2010) Insular cortex activity is associated with effects of negative expectation on nociceptive long-term habituation. J Neurosci 30:11363–11368
55. Sandler AD, Bodfish JW (2008) Open-label use of placebos in the treatment of ADHD: a pilot study. Child Care Health Dev 34:104–110
56. Sandler A, Glesne C, Geller G (2008) Children’s and parents’ perspectives on open-label use of placebos in the treatment of ADHD. Child Care Health Dev 34:111–120
57. Sandler AD, Glesne CE, Bodfish JW (2010) Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? J Dev Behav Pediatr 31:369–375
58. Siegel S, Baptista MA, Kim JA, Mcdonald RV, Eise-Kelly L (2000) Pavlovian psychopharmacology: the associative basis of tolerance. Exp Clin Psychopharmacol 8:276–293
59. Stefani A, Bassi A, Mazzone P, Pierantozzi M, Gattoni G, Altibrandi MG, Giacomini P, Peppe A, Bernardi G, Stanzione P (2002) Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the ‘indirect pathway’. Clin Neurophysiol 113:91–100
60. Subkov AAZ, Zilov GN (1937) The role of conditioned reflex adaption in the origin of hyperergic reactions. Bull Biol Med Exp 4:294–296
61. Swider K, Babel P (2013) The effect of the sex of a model on nocebo hyperalgesia induced by social observational learning. Pain 154:1312–1317
62. Vogtle E, Barke A, Kroner-Herwig B (2013) Nocebo hyperalgesia induced by social observational learning. Pain 154:1427–1433
63. Voudouris NJ, Peck CL, Coleman G (1990) The role of conditioning and verbal expectancy in the placebo response. Pain 43:121–128
64. Wager TD, Matre D, Casey KL (2006) Placebo effects in laser-evoked pain potentials. Brain Behav Immun 20:219–230
65. Woods SC, Makous W, Hutton RA (1969) Temporal parameters of conditioned hypoglycemia. J Comp Physiol Psychol 69:301–307
66. Zhang RR, Zhang WC, Wang JY, Guo JY (2013) The opioid placebo analgesia is mediated exclusively through mu-opioid receptor in rat. Int J Neuropsychopharmacol 16:849–856